Diomed Developments Limited

Tatmore Place, Gosmore, Hitchin, Herts, SG4 7QR
Telephone: +44 (0)1462 458 866
Fax: +44 (0)1462 420 565
WWW: http://www.dermal.co.uk

Summary of Product Characteristics last updated on the eMC: 28/08/2008
SPC Yariba Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/08/2008 and displayed until Current
Reasons for adding or updating:
  • Change to section 6.1 - List of Excipients
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 10 date of revision of the text
  • Change to section 4.4 - Special warnings and precautions for Use
Date of revision of text on the SPC:   01-Apr-2008
Legal Category:   GSL
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

In section 4.4 (Special warnings and precautions for use): The following text has been added "Keep medicines away from children.  Because it contains glucose monohydrate, patients with rare glucose-galactose malabsorption should not take this medicine."

In section 6.1 (List of excipients): "Dextrose Monohydrate" has been replaced with "Glucose Monohydrate"

In section 6.5 (Nature and contents of container): The following text has been removed "This is supplied as an original pack (OP)"

In section 10 (Date of revision of the text): The date has changed to "April 2008"
Updated on 30/01/2007 and displayed until 28/08/2008
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Active Ingredients/Generics

 
   kola nut